Antiinflammatory effect of Oldenlandia diffusa and its constituent, hentriacontane, through suppression of caspase-1 activation in mouse peritoneal macrophages

Phytotherapy Research

Volumn 25, Issue 10, 2011, Pages 1537-1546

  Kim, Su Jin ^a   Chung, Won Seok ^a   Kim, Sung Soo ^a   Ko, Seong Gyu ^a   Um, Jae Young ^a  

^a Kyung Hee University   (South Korea)

Author keywords

caspase 1; hentriacontane; inflammation; macrophage; nuclear factor kappa B; Oldenlandia diffusa

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; HENTRIACONTANE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OLDENLANDIA DIFFUSA EXTRACT; PLANT EXTRACT; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROSPRAY MASS SPECTROMETRY; ENZYME INHIBITION; GAS CHROMATOGRAPHY; MALE; MOUSE; NONHUMAN; OLDENLANDIA; OLDENLANDIA DIFFUSA; PERITONEUM MACROPHAGE; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CASPASE 1; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HYDROCARBONS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MICE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OLDENLANDIA; PHYTOTHERAPY; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

HEDYOTIS DIFFUSA;

EID: 80053353504     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3443     Document Type: Article

References (53)

1. Baeuerle P., Henkel T,. 1994. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12: 141-153.
2. Baldwin AS Jr,. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683. (Pubitemid 26130197)
3. Beutler B,. 1995. TNF, immunity and inflammatory disease: lessons of the past decade. J Investig Med 43: 227-235.
4. Beutler B,. 2000. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 12: 20-26. (Pubitemid 30093446)
5. Blackwell TS, Christman JW,. 1997. The role of nuclear factor-kB in cytokine gene regulation. Am J Respir Cell Mol Biol 17: 3-9. (Pubitemid 127500814)
6. Bochenek G, Nizankowska E, Gielicz A, Swierczyńska M, Szczeklik A,. 2004. Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax 59: 459-464. (Pubitemid 38797516)
7. Bunikowski R, Gerhold K, Bräutigam M, Hamelmann E, Renz H, Wahn U,. 2001. Effect of low-dose cyclosporine a microemulsion on disease severity, interleukin-6, interleukin-8 and tumor necrosis factor alpha production in severe pediatric atopic dermatitis. Int Arch Allergy Immunol 125: 344-348. (Pubitemid 34704647)
8. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, Cheng G,. 2002. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416: 190-194. (Pubitemid 34246478)
9. Crofford LJ, Oates JC, McCune WJ, et al,. 2000. Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase- 2 inhibitors. A report of four cases. Arthritis Rheum 43: 1891-1896.
10. Dharmappa KK, Kumar RV, Nataraju A, Mohamed R, Shivaprasad HV, Vishwanath BS,. 2009. Anti-inflammatory activity of oleanolic acid by inhibition of secretory phospholipase A2. Planta Med 75: 211-215.
11. Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES,. 2001. Regulation of IL-1beta generation by Pseudo-ICE and ICEBERG, two dominant negative caspase recruitment domain proteins. Cell Death Differ 8: 649-657. (Pubitemid 32586602)
12. Eisenach JC, Curry R, Rauck R, Pan P, Yaksh TL,. 2010. Role of spinal cyclooxygenase in human postoperative and chronic pain. Anesthesiology 112: 1225-1233.
13. Faubel S, Lewis EC, Reznikov L, et al,. 2007. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther 322: 8-15. (Pubitemid 46956357)
14. Finco T, Baldwin AS Jr,. 1995. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263-272.
15. Gabay O, Sanchez C, Salvat C, et al,. 2010. Stigmasterol: a phytosterol with potential anti-osteoarthritic properties. Osteoarthritis Cartilage 18: 106-116.
16. Ghosh S, May MJ, Kopp EB,. 1998. NF-κB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16: 225-260. (Pubitemid 28183365)
17. Gupta S, Zhang D, Yi J, Shao J,. 2004. Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother 4: 21-33. (Pubitemid 38495766)
18. Hendrickson BA, Gokhale R, Cho JH,. 2002. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 15: 79-94. (Pubitemid 34052583)
19. Huang Y, Nikolic D, Pendland S, Doyle BJ, Locklear TD, Mahady GB,. 2009. Effects of cranberry extracts and ursolic acid derivatives on P-fimbriated Escherichia coli, COX-2 activity, pro-inflammatory cytokine release and the NF-kappabeta transcriptional response in vitro. Pharm Biol 47: 18-25.
20. Jason GW, Pajurkova EM, Suchowersky O, et al,. 1988. Presymptomatic neuropsychological impairment in Huntington's disease. Arch Neurol 45: 769-773.
21. Jones P, Lamdin R,. 2010. Oral cyclo-oxygenase 2 inhibitors versus other oral analgesics for acute soft tissue injury: systematic review and meta-analysis. Clin Drug Investig 30: 419-437.
22. Kobayashi K, Inohara N, Hernandez LD, et al,. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199. (Pubitemid 34246479)
23. Kopp E, Ghosh S,. 1994. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959.
24. Kuida K, Lippke JA, Ku G, et al,. 1995. Altered cytokine export and apoptosis in mice deficient in interleukin-1B converting enzyme. Science 267: 2000-2002.
25. Lamkanfi M, Kalai M, Saelens X, Declercq W, Vandenabeele P,. 2004. Caspase-1 activates nuclear factor of the kappa-enhancer in B cells independently of its enzymatic activity. J Biol Chem 279: 24785-24793. (Pubitemid 38725346)
26. Lappas M, Permezel M, Georgiou HM, Rice GE,. 2002. Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67: 668-673. (Pubitemid 34803959)
27. Lee SH, Stehlik C, Reed JC,. 2001. Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processing. J Biol Chem 276: 34495-34500.
28. Leiro JM, Alvarez E, Arranz JA, Cano E, Orallo F,. 2004. Antioxidant activity and inhibitory effects of hydralazine on inducible NOS/COX-2 gene and protein expression in rat peritoneal macrophages. Immunopharmacology 4: 163-177. (Pubitemid 38296346)
29. MacMicking J, Xie QW, Nathan C,. 1997. Nitric oxide and macrophage function. Annu Rev Immunol 15: 323-350. (Pubitemid 27169284)
30. Mariathasan S, Newton K, Monack DM, et al,. 2004. Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430: 213-218. (Pubitemid 38902430)
31. Mastbergen SC, Marijnissen AC, Vianen ME, et al,. 2006. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis. Rheumatology 45: 405-413.
32. Meade EA, Smith WL, DeWitt DL,. 1993. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268: 6610-6614. (Pubitemid 23099364)
33. Medzhitov R, Janeway CA Jr,. 1997. Innate immunity: the virtues of a nonclonal system of recognition. Cell 9: 295-298. (Pubitemid 27467959)
34. Morita IM, Schindler MK, Regier JC, Otto T, Hori DL, KeWitt Smith WL,. 1995. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2. J Biol Chem 270: 10902-10908.
35. Murthy SN, Cooper HS, Shim H, Shah RS, Ibarahim SA, Sedergran DJ,. 1993. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 38: 1722-1734. (Pubitemid 23271431)
36. Nagy G, Koncz A, Telarico T, et al,. 2010. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 12: 210.
37. Narumi S, Finke JH, Hamilton TA,. 1990. Interferon gamma and interleukin 2 synergize to induce selective monokine expression in murine peritoneal macrophages. J Biol Chem 265: 7036-7041.
38. Nishimoto N,. 2005. Cytokine signal regulation and autoimmune disorders. Autoimmunity 38: 359-367. (Pubitemid 41358666)
39. Otta JC, Smith WL,. 1995. Prostaglandin endoperoxide synthases-1 and -2. J Lipid Mediat Cell Signal 12: 139-156.
40. Parrillo JE,. 1993. Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477.
41. Pfeilschifter J, Muhl H,. 1999. Immunopharmacology: anti-inflammatory therapy targeting transcription factors. Eur J Pharmacol 30: 237-245. (Pubitemid 29317608)
42. Poyet JL, Srinivasula SM, Tnani M, Razmara M, Fernandes-Alnemri T, Alnemri ES,. 2001. Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J Biol Chem 276: 28309-28313.
43. Roberts PJ, Morgan K, Miller R, Hunter JO, Middleton SJ,. 2001. Neuronal COX-2 expression in human mesenteric plexus in active inflammatory bowel disease. Gut 48: 468-472. (Pubitemid 32234789)
44. Srinivasula SM, Poyet JL, Razmara M, Datta P, Zhang Z, Alnemri ES,. 2002. The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J Biol Chem 277: 21119-21122. (Pubitemid 34952246)
45. Stark LA, Din FV, Zwacka RM, Dunlop MG,. 2001. Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells. FASEB J 15: 1273-1275.
46. Stehlik C, Lee SH, Dorfleutner A, Stassinopoulos A, Sagara J, Reed JC,. 2003. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. J Immunol 171: 6154-6163. (Pubitemid 37467238)
47. Tak PP, Firestein GS,. 2001. NF-κB: a key role in inflammatory disease. J Clin Invest 107: 7-11. (Pubitemid 32047405)
48. Takahashi C, Kikuchi N, Katou N, Miki T, Yanagida F, Umeda M,. 1995. Possible anti-tumour-promoting activity of components in Japanese soybean fermented food, Natto: effect on gap junctional intercellular communication. Carcinogenesis 16: 471-476.
49. Tegeder I, Pfeilschifter J, Geisslinger G,. 2001. Cyclooxygenase- independent actions of cyclooxygenase inhibitors. FASEB J 15: 2057-2072. (Pubitemid 32927924)
50. Thanos D, Maniatis T,. 1995. NF-kappa B: a lesson in family values. Cell 80: 529-532.
51. Vane JR, Botting RM,. 1998. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 47: 578-587.
52. Wang X, Wang HY, Bryan EF, et al,. 2005. Dysregulation of receptor interacting protein-2 and caspase recruitment domain only protein mediates aberrant caspase-1 activation in Huntington's disease. J Neurosci 25: 11645-11654. (Pubitemid 43098457)
53. Woolley DE, Tetlow LC,. 2000. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthritis Res 2: 65-74. (Pubitemid 32223702)